MIP Search | Managing Intellectual Property

Search results for

There are 22,099 results that match your search.22,099 results

Sort by

Expanding exemptions for generics

The Hatch-Waxman Act in the US represented a careful balance of interests between the generic and brand name pharmaceutical manufacturers. William Feiler and Paula Wittmayer examine the Safe Harbor exemption and the challenges it represents to the biotech industry

Managing IP Correspondent, May 31 2003
A dusty road to standards licensing

The GSM story is one of success for the market as well as investors in the technology and IP rights holders, and it will be for the market to resolve the forthcoming issues on 3G IP rights by tried and tested methods, argues Hugh Dunlop

Managing IP Correspondent, May 31 2003
The business of biotech

Survival and success for biotech companies across the US and worldwide is a tenuous and arduous endeavor in today's economy. Robin Silva offers some tips on how to ride the wave successfully

Managing IP Correspondent, May 31 2003
View from the bench

Interview: Judge Arjen Meij, Court of First Instance With an increasing number of Community Trade Mark cases reaching the European courts, Stéphanie Bodoni asks judge Arjen Meij from the European Court of First Instance how well the system is coping

Managing IP Correspondent, May 31 2003
INTA

Snapshots of INTA's 125th Annual Meeting in Amsterdam

Managing IP Correspondent, May 31 2003
SPC guidance sought

A case that will decide how to calculate the length of patent protection for new medicines in the EU has been referred to the European Court of Justice for a preliminary ruling.

Managing IP Correspondent, May 31 2003
Singapore positions itself as IP hub

On February 28 2003 the Singapore government introduced a number of fiscal incentives in the 2003 budget to make Singapore an even more attractive location for IP rights holders.

Managing IP Correspondent, May 31 2003
UK collides with European Parliament on banning of therapeutic cloning

On April 10, the European Parliament, in its first reading of the Tissues and Cells Directive (the Directive), voted in favour of a ban on the creation of human embryos for research purposes including stem cell research. MEPs stopped short of demanding an outright ban on the use of embryonic stem (ES) cells for research. However, they imposed severe restrictions, the effect of which could be to make it difficult for scientists to justify their use.

Managing IP Correspondent, May 31 2003
IN BRIEF: EUROPE

? Italy: The country has joined Greece and Denmark in implementing the EU copyright directive into its national law - with most other EU member states facing the prospect of being taken to the European Court of Justice.

Managing IP Correspondent, May 31 2003
What nanotechnology means for IP

As the race among global leaders spurs exponential growth in nanotechnology, companies must keep watch on intellectual property issues emerging with the new field, explains Vicki Norton

Managing IP Correspondent, May 31 2003

...

2065

2066

2067

2068

2069

...

2209